TheEdgeResearch
Home / Stocks / NXRT

NexPoint Residential Trust, Inc. (NXRT)

NYSE Real Estate REIT - Residential
$24.71 ▲ +0.12%
Market Cap
$627.9M
Sector
Real Estate
Industry
REIT - Residential
Beta
1.19
52-Wk Range
23.79-34.87
CEO
James David Dondero
Country
US
Currency
USD

NexPoint Residential Trust, Inc. operates in the REIT - Residential industry of the Real Estate sector, headquartered in Dallas, TX, US. The stock last traded at $24.71, up 0.12% on the session, giving a market capitalisation of $627.9M. On trailing twelve-month figures it carries a trailing P/E of -18.86, a net margin of -13.1%. Its beta of 1.19 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-18.86
Price / Sales
2.46
Price / Book
2.54
EV / EBITDA
5.95
Gross margin
90.8%
Operating margin
11.1%
Net margin
-13.1%
Return on equity
Debt / equity
6.41
Current ratio
0.49
Dividend yield
8.5%
Payout ratio
-163.2%
Company profile
Exchange
New York Stock Exchange
Employees
1
IPO date
2015-03-19
Headquarters
Dallas, TX, US
About NexPoint Residential Trust, Inc.

NexPoint Residential Trust (NXRT) is a Real Estate Investment Trust publicly traded on the New York Stock Exchange, specializing in the acquisition, ownership, and operation of well-located apartment communities designed for middle-income residents. The company seeks properties offering opportunities for value enhancement in major metropolitan areas and their surrounding suburbs, predominantly situated in the Southeastern and Southwestern United States. NXRT receives external advisory services from NexPoint Real Estate Advisors, L.P., an associate of NexPoint Advisors, L.P., an investment advisor registered with the SEC that possesses extensive experience in the real estate sector.

Comparable companies

NexPoint Residential Trust, Inc. is most often compared with the following Real Estate names:

AIVBFSBRSPCSRCTOFBRTMITPMITTRWT
More research on NXRT
NXRT technical analysis NXRT TheEdge Score Compare against peers
Open full interactive analysis & DCF →